Table 1 Sequence and activity of WCopW-derived AMPs.

From: Matching amino acids membrane preference profile to improve activity of antimicrobial peptides

Componud

Sequencea

Net charge

MW

Minimum inhibitory concentrations (μM)b

MDR P. aeruginosa

MDR A. baumannii

MDR S. aureus

MDR E. faecalis

SCopW

NH2

S

L

L

W

I

A

L

R

K

K

 

CONH2

+4

1226.6

>20

>20

>20

>20

HCopW

NH2

H

L

L

W

I

A

L

R

K

K

 

CONH2

+5

1276.6

>20

>20

>20

>20

WCopW

NH2

W

L

L

W

I

A

L

R

K

K

 

CONH2

+4

1325.7

20

5

5

10

WCopW1

NH2

W

L

L

W

I

A

L

R

K

K

R

CONH2

+5

1481.9

>20

5

2.5

5

WCopW3

NH2

w

l

l

w

i

a

l

r

k

k

r

CONH2

+5

1481.9

5

2.5

1.25

2.5

WCopW5

NH2

w

l

l

w

i

g

l

r

k

k

r

CONH2

+5

1467.9

10

1.25

1.25

2.5

WCopWK

NH2

w

l

k

w

i

g

l

r

k

k

r

CONH2

+6

1482.9

>20

>20

>20

>20

WCopWE

NH2

w

l

e

w

i

g

l

r

k

k

r

CONH2

+4

1483.8

>20

10

>20

>20

WCopWY

NH2

w

l

y

w

i

g

l

r

k

k

r

CONH2

+5

1517.9

20

1.25

10

2.5

WCopWV

NH2

w

l

v

w

i

g

l

r

k

k

r

CONH2

+5

1454.8

10

1.25

2.5

2.5

WCopWF

NH2

w

l

f

w

i

g

l

r

k

k

r

CONH2

+5

1502.9

10

1.25

2.5

2.5

Melittin

              

2846.5

>20

1.25

1.25

1.25

  1. aThe sequence of the coprisin orthologous α-helical region-derived short AMP, WCopW, and its derivatives. Lower case letters indicate d-form amino acids; capital letters, l-form. Hydrophilic position-preferring residues are remarked as bolded letters because of their critical role in matching the preferred membrane position profile.
  2. bThe minimal inhibitory concentrations (MICs) were determined in cation-adjusted Mueller–Hinton broth containing 10 mg/l Mg2+ and 50 mg/l Ca2+ under CLSI conditions. When considering the molecular weight of AMPs (≤1.52 kDa), a MIC of 2.5 μM (≤3.8 μg/ml) (bold letters) could be considered as the “breakpoint” MIC (i.e., <4 μg/ml), but a MIC of 1.25 μM (≤1.9 μg/ml) (bold and underlined letters) is a more confident “breakpoint” MIC (10). Melittin was used as a control because it is one of the most powerful nonclinical AMPs (Table 3 and Supplementary Table S1).